ИШЕМИЧЕСКАЯ БОЛЕЗНЬ СЕРДЦА И ДЕПРЕССИЯ: СПОСОБЫ ДИАГНОСТИКИ И КОРРЕКЦИИ
Аннотация
В обзоре кратко приведены данные литературы об основных способах диагностики и коррекции ишемической болезни сердца и коморбидных депрессивных расстройств.
Литература
Лебедев, А.В. Депрессия, тревога и инфаркт миокарда: все только начинается. Ч. II/ А.В. Лебедев,Ю.А. Васюк .// Рацион. фармакотерапия в кардиол.- 2007. - 3, № 4.- С.39-45.
Мосолов,С.Н. Клиническое применение современных антидепрессантов / С.Н.Мосолов - СПб : Медицинское информационное агентство, 1995. - 568 с.
AAFP Guideline for the Detection and Management of Post-Myocardial Infarction DepressionPost-Myocardial Infarction Depression Clinical Practice Guideline Panel/ [et al.] // Ann Fam Med. - 2009. - . - Vol. 7, № 1. - Р.71-79.
Beta-Blockers and Depression / Glen L [et al.] // Am J Psychiatry - 2010. - Vol. 167 - Р. 219.
Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease/ S.P. Roose [et al.] // JAMA. - 1998. - Vol. 279, № 4. - Р.287-291.
Course of depressive symptoms after myocardial infarction and cardiac prognosis: a latent class analysis / K.I. Kaptein [et al.] // Psychosom Med.. - 2006. - Vol. 65, № 5. - Р.662-668.
Depression screening in patients with CHD/ M. Hasnain [et al.] // J of Psychosomatic Reseach . - 2010. - № 10. - Р.2-11.
Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction / A. McFarlane [et al.] // Am. Heart J. - 2001. - Vol. 142, № 4. - Р.617-623.
Effects of Antidepressant Medication on Morbidity and Mortality in Depressed Patients After Myocardial Infarction / C. B. Taylor [et al.] // JAMA Psychiatry. - 2005. - Vol. 62, № 7. - Р.792-798.
Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) randomized trial / L.F. Berkman [et al.] // JAMA. - 2003. - Vol. 289, № 23. - Р.3106-3116.
Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: Findings from a double-blind, placebo-controlled trial / J.J. Strik [et al.] // Psychosom Med.. - 2000. - Vol. 62, № 6. - Р.783-789.
Exercise and Pharmacotherapy in the Treatment of Major Depressive Disorder / J.A. Blumenthal [et al.] // Psychosomatic Medicine. - 2007. - Vol. 69, № 7. - Р.587-596.
Impact on patients and partners of inpatient and extended cardiac counseling and rehabilitation: a controlled trial / M. Johnston [et al.] // Psychosom Med.. - 1999. - Vol. 61, № 2. - Р.225-233.
In-hospital symptoms of depression do not predict mortality 3 years after myocardial infarction/ L. Deirdre [et al.] // Int. J. Epidemiol. - 2002. - Vol. 31, № 6. - Р.1179-1182.
Membrane Omega-3 Fatty Acid Deficiency as a Preventable Risk Factor for Comorbid Coronary Heart Disease in Major Depressive Disorder [Electronic resource] / R.K. McNamara. - DisorderCardiovascular Psychiatry and Neurology., 2009. - ID 362795, P 13. - Mode of access : downloads.hindawi.com/journals/cpn/2009/362795.pdf- Date of access : 14.01.2013
Preliminary randomized double-blind placebo controlled trial of tryptophan combined with fluoxetine to treat major depressive disorder: antidepressant and hypnotic effects /R. D. Levitan [et al.] // J Psychiatry Neurosci. - 2000. - Vol. 25, №4. - P.337-346.
Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis /Joost P. van Melle [et al.] // Psychosomatic Medicine - 2004. - Vol. 66. - P.814-822.
Sertraline treatment of major depression in patients with acute MI or unstable angina / A.H. Glassman [et al.] // JAMA. - 2002. - Vol. 288, № 6. - Р.701-709.
Social Support, Depression, and Mortality During the First Year After Myocardial Infarction/ N. Frasure-Smith [et al.] // Circulation. - 2000. - Vol. 101. - Р.1919-1924.
Statin Use and Risk of Depression: in patients with coronary heart desease: Longitudinal data from theHeart and soul study / Otte Ch [et al.] // Clin.Psychiatry - 2012. - Vol. 73, № 5. - Р.610-615.
